Neoadjuvant S-1 with concurrent radiotherapy followed by surgery for borderline resectable pancreatic cancer: study protocol for an open-label, multicentre, prospective phase II trial (JASPAC05)

INTRODUCTION: Borderline resectable pancreatic cancer (BRPC) can involve the portal vein, superior mesenteric vein, superior mesenteric artery, coeliac axis or hepatic artery, and has a high probability of positive surgical margins and poor prognosis after resection. Neoadjuvant chemoradiation is ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Takahashi, Shinichiro, Ohno, Izumi, Ikeda, Masafumi, Kobayashi, Tatsushi, Akimoto, Tetsuo, Kojima, Motohiro, Konishi, Masaru, Uesaka, Katsuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5665261/
https://www.ncbi.nlm.nih.gov/pubmed/29061632
http://dx.doi.org/10.1136/bmjopen-2017-018445

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5665261/
https://www.ncbi.nlm.nih.gov/pubmed/29061632
http://dx.doi.org/10.1136/bmjopen-2017-018445

Ejemplares similares